Related Experiment Video
Updated: Jun 12, 2026
06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
Turning principles into practice in Alzheimer's disease.
J Lindesay1, R Bullock, H Daniels
1University of Leicester, Leicester, UK. jebl1@leicester.ac.uk
International Journal of Clinical Practice
|June 10, 2010
Summary
Dementia prevalence is rising globally, impacting patients and caregivers. This review addresses challenges in dementia diagnosis and care, aligning with the Alzheimer's Disease International Charter principles for better management.
Area of Science:
- Neurology
- Public Health
- Gerontology
Background:
- Global dementia prevalence is increasing, posing significant challenges to individuals, families, and caregivers.
- Existing issues hinder effective management and control of dementia conditions.
- The Alzheimer's Disease International (ADI) Global Alzheimer's Disease Charter (2008) outlines six key principles for a proactive approach.
Purpose of the Study:
- To review critical aspects and challenges in dementia diagnosis and treatment.
- To evaluate current practices against the six principles of the ADI Charter.
- To emphasize the need for improved dementia care strategies.
Main Methods:
- Literature review and analysis of current dementia diagnosis and treatment strategies.
- Discussion of challenges in dementia care in the context of the ADI Charter principles.
- Synthesis of information to highlight areas for improvement in dementia management.
Main Results:
- Significant challenges persist in dementia diagnosis, treatment, and overall care.
- Alignment with ADI Charter principles is crucial for advancing dementia care.
- Key areas for focus include awareness, human rights, caregiver support, healthcare access, optimal diagnosis/treatment, and public health interventions.
Conclusions:
- While a cure for Alzheimer's disease remains elusive, immediate improvements in patient care are achievable.
- Healthcare professionals must collaborate to manage dementia effectively using available tools.
- Implementing the ADI Charter principles is essential for enhancing the lives of those affected by dementia.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.